Cornerstone Advisors (Washington)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,335
Closed -$246K 817
2019
Q2
$246K Buy
1,335
+66
+5% +$11.8K 0.02% 119
2019
Q1
$241K Buy
1,269
+29
+2% +$5.54K 0.02% 115
2018
Q4
$241K Buy
1,240
+109
+10% +$21.3K 0.04% 96
2018
Q3
$234K Buy
1,131
+355
+46% +$70K 0.15% 108
2018
Q2
$143K Buy
776
+47
+6% +$8.31K 0.1% 157
2018
Q1
$124K Buy
729
+316
+77% +$58K 0.08% 167
2017
Q4
$72K Hold
413
0.05% 227
2017
Q3
$77K Hold
413
0.05% 216
2017
Q2
$71K Sell
413
-198
-32% -$32.2K 0.04% 227
2017
Q1
$100K Buy
611
+172
+39% +$28.6K 0.05% 188
2016
Q4
$64K Sell
439
-848
-66% -$128K 0.05% 224
2016
Q3
$215K Buy
1,287
+864
+204% +$146K 0.18% 77
2016
Q2
$64K Hold
423
0.07% 134
2016
Q1
$63K Buy
423
+117
+38% +$17.4K 0.07% 138
2015
Q4
$50K Hold
306
0.05% 177
2015
Q3
$42K Buy
306
+54
+21% +$8.51K 0.04% 196
2015
Q2
$39K Buy
252
+15
+6% +$2.4K 0.03% 190
2015
Q1
$38K Sell
237
-26
-10% -$4.09K 0.03% 218
2014
Q4
$42K Buy
263
+33
+14% +$5.14K 0.03% 199
2014
Q3
$32K Sell
230
-13
-5% -$1.7K 0.03% 98
2014
Q2
$29K Sell
243
-6
-2% -$695 0.03% 118
2014
Q1
$31K Buy
249
+167
+204% +$20.3K 0.04% 105
2013
Q4
$9K Buy
82
+4
+5% +$455 0.01% 150
2013
Q3
$9K Buy
78
+6
+8% +$651 0.02% 140
2013
Q2
$7K Buy
+72
New +$7.47K 0.02% 102

Other funds holding AMGN

Cornerstone Advisors (Washington)'s AMGN Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Amgen (AMGN) in Q3 2019, closing a stake of 1,335 shares — an estimated $246K sold.

Cornerstone Advisors (Washington) first reported a position in AMGN in Q2 2013 and held it in 25 quarters. The position peaked at $246K in Q2 2019. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 1,335 Amgen shares in Q3 2019, an estimated $246K.
  • Cornerstone Advisors (Washington) first reported a position in Amgen in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s Amgen position peaked at $246K in Q2 2019.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.